Works by Pricop, Luminita

Results: 27

Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients.
Published in:
2020
By:
- Orbai, Ana-Maria;
- McInnes, Iain B.;
- Coates, Laura C.;
- Husni, M. Elaine;
- Gladman, Dafna D.;
- Gossec, Laure;
- Pricop, Luminita;
- Chambenoit, Olivier;
- Xiangyi Meng;
- Mease, Philip J.;
- Meng, Xiangyi
Publication type:
journal article
Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis.
Published in:
2020
By:
- Deodhar, Atul;
- Gladman, Dafna D.;
- McInnes, Iain B.;
- Spindeldreher, Sebastian;
- Martin, Ruvie;
- Pricop, Luminita;
- Porter, Brian;
- Safi Jr., Jorge;
- Shete, Abhijit;
- Bruin, Gerard;
- Safi, Jorge Jr
Publication type:
journal article
Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus.
Published in:
Human Genetics, 2005, v. 117, n. 2/3, p. 220, doi. 10.1007/s00439-005-1302-3
By:
- Blank, Marissa C.;
- Stefanescu, Radu N.;
- Masuda, Emi;
- Marti, Francesc;
- King, Philip D.;
- Redecha, Patricia B.;
- Wurzburger, Robert J.;
- Peterson, Margaret G. E.;
- Tanaka, Shizuko;
- Pricop, Luminita
Publication type:
Article
Study of Self Reactive Antibodies in Kappa-Light Chain Deficient Mice.
Published in:
Autoimmunity, 1995, v. 20, n. 2, p. 113, doi. 10.3109/08916939509001935
By:
- Hatakeyama, Akira;
- Pricop, Luminita;
- Swamy, Kuppu;
- Kasturi, N.;
- Bona, Constantin A.
Publication type:
Article
Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study.
Published in:
Arthritis Care & Research, 2017, v. 69, n. 3, p. 347, doi. 10.1002/acr.23111
By:
- Kavanaugh, Arthur;
- Mease, Philip J.;
- Reimold, Andreas M.;
- Tahir, Hasan;
- Rech, Jürgen;
- Hall, Stephen;
- Geusens, Piet;
- Wang, Zailong;
- Pricop, Luminita;
- Mpofu, Shephard
Publication type:
Article
Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study.
Published in:
2016
By:
- Kavanaugh, Arthur;
- Mease, Philip J;
- Reimold, Andreas M;
- Tahir, Hasan;
- Rech, Jürgen;
- Hall, Stephen;
- Geusens, Piet;
- Wang, Zailong;
- Pricop, Luminita;
- Mpofu, Shephard;
- FUTURE-1 Study Group
Publication type:
journal article
Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies.
Published in:
Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-2055-z
By:
- Coates, Laura C.;
- Wallman, Johan K.;
- McGonagle, Dennis;
- Schett, Georg A.;
- McInnes, Iain B.;
- Mease, Philip J.;
- Rasouliyan, Lawrence;
- Quebe-Fehling, Erhard;
- Asquith, Darren L.;
- Fasth, Andreas E. R.;
- Pricop, Luminita;
- Gaillez, Corine
Publication type:
Article
Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study.
Published in:
Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1610-3
By:
- McInnes, Iain B.;
- Mease, Philip J.;
- Schett, Georg;
- Kirkham, Bruce;
- Strand, Vibeke;
- Williams, Nicole;
- Fox, Todd;
- Pricop, Luminita;
- Jugl, Steffen M.;
- Gandhi, Kunal K.;
- on behalf of the FUTURE 2 Study Group
Publication type:
Article
Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3).
Published in:
Arthritis Research & Therapy, 2018, v. 20, p. 1, doi. 10.1186/s13075-018-1551-x
By:
- Nash, Peter;
- Mease, Philip J.;
- McInnes, Iain B.;
- Rahman, Proton;
- Ritchlin, Christopher T.;
- Blanco, Ricardo;
- Dokoupilova, Eva;
- Andersson, Mats;
- Kajekar, Radhika;
- Mpofu, Shephard;
- Pricop, Luminita;
- on behalf of the FUTURE 3 study group
Publication type:
Article
Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3.
Published in:
Arthritis Research & Therapy, 2017, v. 19, p. 1, doi. 10.1186/s13075-017-1490-y
By:
- Pavelka, Karel;
- Kivitz, Alan;
- Dokoupilova, Eva;
- Blanco, Ricardo;
- Maradiaga, Marco;
- Tahir, Hasan;
- Pricop, Luminita;
- Andersson, Mats;
- Readie, Aimee;
- Porter, Brian
Publication type:
Article
Correlation of F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 3, p. 403, doi. 10.1007/s00259-012-2282-x
By:
- Roivainen, Anne;
- Hautaniemi, Sannamari;
- Möttönen, Timo;
- Nuutila, Pirjo;
- Oikonen, Vesa;
- Parkkola, Riitta;
- Pricop, Luminita;
- Ress, Rudyard;
- Seneca, Nicholas;
- Seppänen, Marko;
- Yli-Kerttula, Timo
Publication type:
Article
Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data.
Published in:
Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.563
By:
- GOTTLIEB, Alice B.;
- DEODHAR, Atul;
- MCINNES, Iain B.;
- BARALIAKOS, Xenofon;
- REICH, Kristian;
- SCHREIBER, Stefan;
- Weibin BAO;
- MARFO, Kwaku;
- RICHARDS, Hanno B.;
- PRICOP, Luminita;
- SHETE, Abhijit;
- TRIVEDI, Vivek;
- KEEFE, Deborah;
- PAPAVASSILIS, Charis C.;
- JAGIELLO, Piotr;
- PAPANASTASIOU, Philemon;
- MEASE, Philip J.;
- LEBWOHL, Mark
Publication type:
Article
Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis.
Published in:
Arthritis & Rheumatology, 2016, v. 68, n. 8, p. 1914, doi. 10.1002/art.39685
By:
- van der Heijde, Désirée;
- Landewé, Robert B.;
- Mease, Philip J.;
- McInnes, Iain B.;
- Conaghan, Philip G.;
- Pricop, Luminita;
- Ligozio, Greg;
- Richards, Hanno B.;
- Mpofu, Shephard
Publication type:
Article
Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5.
Published in:
Rheumatology, 2020, v. 59, n. 6, p. 1325, doi. 10.1093/rheumatology/kez420
By:
- Heijde, Désirée van der;
- Mease, Philip J;
- Landewé, Robert B M;
- Rahman, Proton;
- Tahir, Hasan;
- Singhal, Atul;
- Boettcher, Elke;
- Navarra, Sandra;
- Zhu, Xuan;
- Ligozio, Gregory;
- Readie, Aimee;
- Mpofu, Shephard;
- Pricop, Luminita
Publication type:
Article
263 Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in patients with psoriatic arthritis and ankylosing spondylitis during a 52week treatment period.
Published in:
2019
By:
- McInnes, Iain B;
- Deodhar, Atul;
- Gladman, Dafna D;
- Ren, Mengyuan;
- Spindeldreher, Sebastian;
- Pricop, Luminita;
- Porter, Brian;
- Safi, Jorge;
- Shete, Abhijit;
- Bruin, Gerard
Publication type:
Abstract
258 Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: final 5-year efficacy and safety results from the FUTURE 1 Phase 3 trial.
Published in:
2019
By:
- Tahir, Hasan;
- Mease, Philip J;
- Kavanaugh, Arthur;
- Reimold, Andreas;
- Rech, Jürgen;
- Hall, Stephen;
- Geusens, Piet;
- Pellet, Pascale;
- Delicha, Eumorphia Maria;
- Pricop, Luminita;
- Mpofu, Shephard
Publication type:
Abstract
257 Secukinumab demonstrates a consistent safety profile with up to 5 years' treatment in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses.
Published in:
2019
By:
- McInnes, Iain B;
- Mease, Philip J;
- Reich, Kristian;
- Nash, Peter;
- Widmer, Albert;
- Abrams, Ken;
- Pricop, Luminita;
- Fox, Todd
Publication type:
Abstract
256 Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 4-year results from the Phase 3 FUTURE 2 study.
Published in:
2019
By:
- McInnes, Iain B;
- Kirkham, Bruce;
- Nash, Peter;
- Rahman, Proton;
- Gottlieb, Alice B;
- Ding, Kevin;
- Pricop, Luminita
Publication type:
Abstract
254 Impact of secukinumab treatment on psoriatic arthritis patients with or without enthesitis at baseline: pooled data from FUTURE 2 AND FUTURE 3 Phase 3 studies.
Published in:
2019
By:
- McInnes, Iain B;
- Wallman, Johan K;
- Schett, Georg;
- Quebe-Fehling, Erhard;
- Rasouliyan, Lawrence;
- Pricop, Luminita;
- Fasth, Andreas E;
- Gaillez, Corine
Publication type:
Abstract
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study.
Published in:
Rheumatology, 2017, v. 56, n. 11, p. 1993, doi. 10.1093/rheumatology/kex301
By:
- McInnes, Iain B.;
- Mease, Philip J.;
- Ritchlin, Christopher T.;
- Rahman, Proton;
- Gottlieb, Alice B.;
- Kirkham, Bruce;
- Kajekar, Radhika;
- Delicha, Eumorphia-Maria;
- Pricop, Luminita;
- Mpofu, Shephard
Publication type:
Article
Efficacy and Safety of Secukinumab in US Patients with Psoriatic Arthritis: A Subgroup Analysis of the Phase 3 FUTURE Studies.
Published in:
Rheumatology & Therapy, 2024, v. 11, n. 3, p. 675, doi. 10.1007/s40744-024-00666-1
By:
- Kivitz, Alan J.;
- Kremer, Joel M.;
- Legerton III, Clarence W.;
- Pricop, Luminita;
- Singhal, Atul
Publication type:
Article
Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 Study.
Published in:
Rheumatology & Therapy, 2019, v. 6, n. 3, p. 393, doi. 10.1007/s40744-019-0163-5
By:
- Kivitz, Alan J.;
- Nash, Peter;
- Tahir, Hasan;
- Everding, Andrea;
- Mann, Heřman;
- Kaszuba, Andrzej;
- Pellet, Pascale;
- Widmer, Albert;
- Pricop, Luminita;
- Abrams, Ken
Publication type:
Article
Sequential knockoffs for continuous and categorical predictors: With application to a large psoriatic arthritis clinical trial pool.
Published in:
2021
By:
- Kormaksson, Matthias;
- Kelly, Luke J.;
- Zhu, Xuan;
- Haemmerle, Sibylle;
- Pricop, Luminita;
- Ohlssen, David
Publication type:
journal article
Antibody response against poly (Glu.
Published in:
European Journal of Immunology, 1995, v. 25, n. 4, p. 1039, doi. 10.1002/eji.1830250427
By:
- Pricop, Luminita;
- Hatakeyama, Akira;
- Moran, Tom;
- Bona, Constantin
Publication type:
Article
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5‐year Results from the Phase 3 FUTURE 1 Study.
Published in:
ACR Open Rheumatology, 2020, v. 2, n. 1, p. 18, doi. 10.1002/acr2.11097
By:
- Mease, Philip J.;
- Kavanaugh, Arthur;
- Reimold, Andreas;
- Tahir, Hasan;
- Rech, Juergen;
- Hall, Stephen;
- Geusens, Piet;
- Pellet, Pascale;
- Delicha, Eumorphia Maria;
- Pricop, Luminita;
- Mpofu, Shephard
Publication type:
Article
Quantification of pre-existing radiographic damage and its relationship with joint activity and long-term clinical outcomes with secukinumab therapy in patients with psoriatic arthritis.
Published in:
Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02944-1
By:
- Mease, Philip;
- van der Heijde, Désirée;
- Kirkham, Bruce;
- Schett, Georg;
- Orbai, Ana-Maria;
- Ritchlin, Christopher;
- Merola, Joseph F.;
- Pricop, Luminita;
- James, David A.;
- Zhu, Xuan;
- Ligozio, Gregory
Publication type:
Article
Repertoires of Antigen Receptors in Tdt Congenitally Deficient Mice.
Published in:
International Reviews of Immunology, 1996, v. 13, n. 4, p. 317, doi. 10.3109/08830189609061755
By:
- Komori, Toshihisa;
- Pricop, Luminita;
- Hatakeyama, Akira;
- Bona, Constantin A.;
- Alt, Frederick W.
Publication type:
Article